Episode
Beyond the basics management of complex ADHD patients. When GPs should decline shared care. - Primary Care Masterclass Podcast
- Published
- Aug 8, 2026
- Duration seconds
- 1900
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/general-practice-clinical-sessions-podcast-7705659/episodes/beyond-the-basics-management-of-complex-adhd-patients-when-gps-should-decline-shared-care-primary-care-masterclass-podcast/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/general-practice-clinical-sessions-podcast-7705659/beyond-the-basics-management-of-complex-adhd-patients-when-gps-should-decline-shared-care-primary-care-masterclass-podcast.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr. Vicki Nahamkes presents a guide for General Practitioners on managing complex ADHD patients, emphasizing that while treatment is rewarding, it requires rigorous monitoring and boundary setting. She introduces a "3C Rule" for patient reviews, assessing **Mental Clarity** (organized thinking), **Calm** (mood regulation), and **Consistency** (sleep, diet, and exercise). Cardiovascular safety is a primary concern, particularly for older patients. Dr. Nahamkes advises a cardiovascular risk assessment before starting stimulants, aiming for a risk score below 5%. Regular blood pressure checks are mandatory, as stimulants can increase pressure by 2–4 mmHg; hypertension must be managed or the stimulant withdrawn. A significant portion of the talk addresses special populations and comorbidities: * **Women’s Health:** Hormonal fluctuations during menopause can severely destabilize ADHD control. Dr. Nahamkes shares a case where a patient required increased stimulant dosage and Hormone Replacement Therapy to regain stability. * **Binge Eating Disorder:** She notes that Vyvanse is the only stimulant evidence-based for this comorbidity. * **Bipolar Disorder:** There is a risk of stimulants unmasking mania. A detailed case study describes a patient who developed hypersexuality and reckless behavior upon starting stimulants, eventually requiring a transition to mood stabilizers like Lamotrigine instead of ADHD medication. Dr. Nahamkes concludes with clinical pearls, noting that successful treatment often results in *decreased* steps on fitness trackers, indicating less chaotic movement and better organization. Finally, she empowers GPs to decline "shared care" for patients with complex presentations—such as those with Cluster B personality traits or unstable bipolar disorder—statin…